Skip to main content
We may receive compensation from affiliate partners for some links on this site. Read our full Disclosure here.

New Study Reveals The Truth about Hydroxychloroquine’s Effectiveness


The lies that were spread during the COVID-19 ‘pandemic’ continue to haunt us even today.

Certain people in very high places fought tooth and nail in order to cloud the facts about the virus itself, as well as its treatment.

The man at the head of the snake publicly was America’s most untrustworthy doctor, Anthony Fauci.

Fauci changed his story time and time again, but the one thing he remained steadfast about was the idea that the drug hydroxychloroquine was ineffective against COVID.

A new French study reveals that simply wasn’t the case.

According to the study from a French facility, only 0.8 percent of the patients who took HCQ with an antibiotic ended up dying.

This is compared to the 4.8 percent of the patients who died that did not receive the treatment.

That is a major difference.

ADVERTISEMENT

As we’ve said here before, the truth always eventually comes out.

It’s just always held back as much as possible by those in high places.

Here’s more on the French study from the Gateway Pundit:

HCQ effectiveness improves with earlier usage and improved dosing. But early treatment consistently shows positive effects. That’s the science.

Now a new French study found using Hydroxychloroquine significantly lowered the mortality rates of COVID-19 patients.

Just 0.8 percent of patients at a facility in France who received hydroxychloroquine (HCQ) and an antibiotic died, compared to 4.8 percent of patients who did not receive the drug combination.

The Epoch Times sheds more light on the study:

People who received hydroxychloroquine were less likely to die than those who did not, according to a new study.

ADVERTISEMENT

Just 0.8 percent of patients at a facility in France who received hydroxychloroquine (HCQ) and an antibiotic died, compared to 4.8 percent of patients who did not receive the drug combination, French researchers reported on Nov. 1.

“This study represents the largest single-center study evaluating HCQ-AZ in the treatment of COVID-19. Similarly, to other large observational studies, it concludes that HCQ would have saved lives,” Dr. Didier Raoult, with Aix-Marseille Universite in Marseille, and his co-authors wrote.

The paper was published in the journal New Microbes and New Infections. It was released as a preprint earlier this year, but withdrawn because authors said they have changed their “analytic strategies.”

ADVERTISEMENT


 

Join the conversation!

Please share your thoughts about this article below. We value your opinions, and would love to see you add to the discussion!

Leave a comment
Thanks for sharing!